A nonprofit that's helping train the future drug manufacturing workforce is opening its new space at the mixed-use Allston Labworks campus.

The company's molecular research and drug-development platform taps what it calls nature's wisdom to drive the discovery of ...

In ulcerative colitis, duvakitug led to clinical remission in up to 48% of patients, with placebo-adjusted rates of 27% at the highest dose. In Crohn's disease, duvakitug achieved endoscopic ...

Detailed trial results could help Sanofi and Teva Pharmaceuticals make a case that a drug they’ve been developing will be competitive with rival treatments from Merck & Co. and Roche. The data, ...

Today, a brief rundown of news involving Sanofi and Supernus Pharmaceuticals, as well as updates from Arcus Biosciences, Gilead Sciences and Ultragenyx Pharmaceutical that you might have missed. Over ...

Unsurprisingly, it’s focused on AI. Called Thinking Machines Lab, the startup, which came out of stealth today, intends to build tooling to “make AI work for [people’s] unique needs and ...

Today she announced that indeed she is the CEO of a new public benefit corporation called Thinking Machines Lab. Its mission is to develop top-notch AI with an eye toward making it useful and ...

Also Read: Sanofi/Johnson & Johnson Partnered Vaccine Against Bacterial Sepsis Flunks Late-Stage Study As a rapid-acting insulin, Merilog helps lower mealtime blood sugar spikes and improve blood ...

Regeneron (REGN) and Sanofi (SNY) announced that the FDA has accepted for priority review the supplemental biologics license application for Dupixent to treat adults with bullous pemphigoid.

The "Fasten Your Space Belts' mission lifted off at 6:17 p.m. ET today (Feb. 18). Rocket Lab launched a high-resolution Earth-imaging satellite toward low Earth orbit this evening (Feb. 18).

Approval of biosimilar products can increase patient access to safe and effective treatment options. The FDA granted approval of Merilog to Sanofi-Aventis U.S. LLC. “The FDA has now approved three ...